Adrenomedullin (ADM) inhibits endothelial insulin signaling, contributing to obesity-associated insulin resistance, according ...
22h
News Medical on MSNAdrenomedullin hormone as key driver of insulin resistance in obesity-linked type 2 diabetesResearchers investigate the underlying mechanisms of endothelial insulin resistance involved in obesity-associated diabetes.
If insulin can’t get out of blood vessels, it can’t act in its target tissues. “Endothelial cells are full of insulin ...
If California patients pay more than $35 per month for insulin now, it’s in large part because PBMs have rigged the system in ...
6h
News Medical on MSNNew UVA clinical trial explores AI-powered insulin delivery for better diabetes careFor people living with Type 1 Diabetes, keeping blood sugar levels in check is a constant challenge. A new clinical trial at ...
Surrogate measures of insulin resistance, based on the triglyceride-glucose index, can be used to predict the development of ...
NEW YORK - Oramed Pharmaceuticals Inc . (NASDAQ:ORMP), a clinical-stage pharmaceutical company with a market capitalization of $87 million, has announced the formation of a new joint venture, OraTech ...
12h
Money Talks News on MSNWeight Loss Drug Success Threatens Insulin ProductionThe world's leading insulin manufacturer faces critical decisions as weight-loss drug demand strains production capacity. Market forces threaten the company's ability to serve all patients effectively ...
How does the body regulate the activity of insulin-producing cells in order to react quickly to changing conditions? Researchers have investigated this question.
Minnesota Attorney General Keith Ellison and pharmaceutical company Novo Nordisk reached a settlement to cap insulin costs at ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results